A Clinical Trial to Study the Efficacy and Safety of Different Doses of Bone Marrow Derived Mesenchymal Stem Cells in Patients With Critical Limb Ischemia Due to Buergers Disease

Clinical trial NCT01484574 · COMPLETED

Trial details

NCT number: NCT01484574
Sponsor: Stempeutics Research Pvt Ltd
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Critical Limb Ischemia Buerger's Disease

Start date: 2012-01-01
Primary completion: 2014-02-01
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.